Similar Items: Integrating Molecular Pathology, Tumor Microenvironment, and Novel Therapies to Overcome Resistance in Glioblastoma
- The future of targeted therapies for pediatric central nervous system tumors
- Targeted therapies in adolescent and young adult patients with central nervous system tumors
- Correction to “Efficacy Assessment of Supra‐Marginal Resection Versus Gross Total Resection in Glioblastoma: A Systematic Literature Review and Meta‐Analysis”
- FGFR alterations and potential role of FGFR inhibitors in pediatric brain tumors
- Integrated Transcriptome Analysis Reveals Molecular Subtypes and ceRNA Networks in Multiple Sclerosis
- MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors